Blog

■ How I treat….alcohol-related liver disease

L D Tyson, H Lewis

Clin Med (Lond) 2019, vol 19 (1): 43-46

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399631/

 

■ Severe alcoholic hepatitis: current perspectives

Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol et al

Hepat Med. 2019; 11: 97–108.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691395/

 

■ Alcohol-related liver disease: time for action

Ramon Bataller, Gavin E. Arteel, Christophe Moreno, Vijay Shah

J Hepatol. 2019, vol; 70(2): 221–222

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416779/

 

■ Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes

Nicole T Shen, Cristina Londono, Stephanie Gold, Ashley Wu, Keith C Mages, Robert S Jr Brown

World J Gastroenterol. 2019 Apr 7; 25(13): 1628–1639

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452234/

 

■ Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations

Alexander J. Kovalic, George Cholankeril, Sanjaya K. Satapathy

Transl Gastroenterol Hepatol. 2019; 4: 65

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789306/

 

■ Doença hepática alcoólica no Brasil, uma visão epidemiológica

B B Meneguetti, A S Rocha, D F Vasconcelos et al

Cadernos de Medicina da UNIFESO 2018, vol 1 (1)

http://www.revista.unifeso.edu.br/index.php/cadernosdemedicinaunifeso/article/view/953

 

■ ACG Clinical Guideline: Alcoholic liver disease

Ashwani K. Singal, Ramon Bataller, Joseph Ahn, Patrick S. Kamath, Vijay H. Shah

Am J Gastroenterol. 2018 Feb; 113(2): 175–194

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524956/

 

■ Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis

Lancharat Chuncharunee, Noriyo Yamashiki, Ammarin Thakkinstian, Abhasnee Sobhonslidsuk

BMC Gastroenterol. 2019; 19: 150

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704694/

 

■ Alcoholic liver disease: a current molecular and clinical perspective

Koichiro Ohashi, Michael Pimienta, Ekihiro Seki

Liver Res. 2018 Dec; 2(4): 161–172

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581514/

 

■ Genetic and epigenetic modifiers of alcoholic liver disease

Marica Meroni, Miriam Longo, Raffaela Rametta, Paola Dongiovanni

Int J Mol Sci. 2018 Dec; 19(12): 3857

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320903/

 

■ Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease)

Elena Buzzetti, Maria Kalafateli, Douglas Thorburn et al

Cochrane Database Syst Rev. 2017 Mar; 2017(3): CD011646

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464309/

 

■ Alcoholic liver disease: alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects

Rolf Teschke

Biomedicines. 2018 Dec; 6(4): 106

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316574/

 

■ Transplantation for alcohol-related liver disease: Is it fair?

Jessica L Mellinger, Michael L Volk

Alcohol Alcohol. 2018 Mar; 53(2): 173–177

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355095/

 

■ Hepatite alcoólica aguda: Artigo de revisão.

Matos, Luís et al.

J Port Gastrenterol., Jul 2013, vol.20, no.4, p.153-161

http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782013000400004&lng=pt&nrm=iso

 

■ Pathogenesis and management of alcoholic liver disease

M O Farooq, R Bataller

Dig Dis 2016, vol 34: 347-355

https://www.karger.com/Article/Fulltext/444545

 

■ Hepatopatia Alcoólica Online (Alcoholic Liver Disease)

https://internetmedica.com.br/hepatopatia-alcoolica-online-alcoholic-liver-disease/

 

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

■ Hypertrophic obstructive cardiomyopathy: the role of myectomy and percutaneous septal ablation in drug-refractory disease

Angelika Batzner, Hans-Joachim Schäfers, Konstantin V. Borisov, Hubert Seggewi

Dtsch Arztebl Int. 2019 Jan; 116(4): 47–53

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415619/

 

■ Papel da Fibrose Miocárdica na Cardiomiopatia Hipertrófica: Revisão Sistemática e Metanálise Atualizada de Marcadores de Risco para Morte Súbita

Marcelo Imbroinise Bittencourt, Samária Ali Cader, Denizar Vianna Araújo et al

Arq Bras Cardiol. 2019, vol 112(3): 281–289

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2019000300281&lng=en&nrm=iso&tlng=pt (portuguese)

 

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2019000300281&lng=en&nrm=iso&tlng=en (english)

 

■ Cardiology: hypertrophic cardiomyopathy

Medical Masterclass contributors, edited by John Firth

Clin Med (Lond) 2019 Jan; 19(1): 61–63

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399630/

 

■ Hypertrophic cardiomyopathy: genetics and clinical perspectives

Cordula Maria Wolf

Cardiovasc Diagn Ther. 2019, vol 9(Suppl 2): –S415

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837941/

 

■ Cardiomyopathy and pregnancy

Maria Schaufelberger

Heart. 2019 Oct; 105(20): 1543–1551

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839719/

 

■ Evaluating the clinical validity of hypertrophic cardiomyopathy genes

Jodie Ingles, Jennifer Goldstein, Courtney Thaxton et al

Circ Genom Precis Med. 2019, vol 12(2): e002460

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410971/

 

■ Right ventricular pacing for hypertrophic obstructive cardiomyopathy: meta-analysis and meta-regression of clinical trials

Ahran D Arnold, James P Howard, Kayla Chiew et al

Eur Heart J Qual Care Clin Outcomes. 2019, vol 5(4): 321–333

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775860/

 

■ Risk stratification in pediatric hypertrophic cardiomyopathy: insights for bridging the evidence gap?

Stephanie J. Nakano, Shaji C. Menon

Prog Pediatr Cardiol. 2018 Jun; 49: 31–37

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516538/

 

■ Apical hypertrophic cardiomyopathy: diagnosis, medical and surgical treatment

Jerzy Paluszkiewicz, Beata Krasinska, Hendrik Milting, Jan Gummert, Małgorzata Pyda

Kardiochir Torakochirurgia Pol. 2018 Dec; 15(4): 246–25

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329883/

 

■ Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therap

A J Marian, E Braunwald

Circ Res 2017, vol 121 (7): 749-770

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654557/

 

■ Hypertrophic cardiomyopathy – past, present and future

A C Liew, V S Vassiliou, C E Raphael

J Clin Med 2017, vol 6 (12): 118

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742807/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: Jan 2020